Matches in Wikidata for { <http://www.wikidata.org/entity/Q87666674> ?p ?o ?g. }
- Q87666674 description "2018 nî lūn-bûn" @default.
- Q87666674 description "2018年の論文" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年学术文章" @default.
- Q87666674 description "2018年學術文章" @default.
- Q87666674 description "2018年學術文章" @default.
- Q87666674 description "2018年學術文章" @default.
- Q87666674 description "2018年學術文章" @default.
- Q87666674 description "2018年學術文章" @default.
- Q87666674 description "2018년 논문" @default.
- Q87666674 description "article científic" @default.
- Q87666674 description "article scientific" @default.
- Q87666674 description "article scientifique" @default.
- Q87666674 description "articol științific" @default.
- Q87666674 description "articolo scientifico" @default.
- Q87666674 description "artigo científico" @default.
- Q87666674 description "artigo científico" @default.
- Q87666674 description "artigo científico" @default.
- Q87666674 description "artikel ilmiah" @default.
- Q87666674 description "artikull shkencor" @default.
- Q87666674 description "artikulong pang-agham" @default.
- Q87666674 description "artykuł naukowy" @default.
- Q87666674 description "artículo científico publicado en 2018" @default.
- Q87666674 description "artículu científicu" @default.
- Q87666674 description "bilimsel makale" @default.
- Q87666674 description "bài báo khoa học" @default.
- Q87666674 description "naučni članak" @default.
- Q87666674 description "scienca artikolo" @default.
- Q87666674 description "scientific article published in November 2018" @default.
- Q87666674 description "scientific article published in November 2018" @default.
- Q87666674 description "scientific article published on 01 November 2018" @default.
- Q87666674 description "teaduslik artikkel" @default.
- Q87666674 description "tieteellinen artikkeli" @default.
- Q87666674 description "tudományos cikk" @default.
- Q87666674 description "vedecký článok" @default.
- Q87666674 description "vetenskaplig artikel" @default.
- Q87666674 description "videnskabelig artikel udgivet november 2018" @default.
- Q87666674 description "vitenskapelig artikkel" @default.
- Q87666674 description "vitskapeleg artikkel" @default.
- Q87666674 description "vědecký článek" @default.
- Q87666674 description "wetenschappelijk artikel" @default.
- Q87666674 description "wissenschaftlicher Artikel" @default.
- Q87666674 description "επιστημονικό άρθρο" @default.
- Q87666674 description "мақолаи илмӣ" @default.
- Q87666674 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q87666674 description "научна статия" @default.
- Q87666674 description "научная статья" @default.
- Q87666674 description "научни чланак" @default.
- Q87666674 description "научни чланак" @default.
- Q87666674 description "מאמר מדעי" @default.
- Q87666674 description "مقالة علمية نشرت في نوفمبر 2018" @default.
- Q87666674 description "নভেম্বর ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q87666674 description "บทความทางวิทยาศาสตร์" @default.
- Q87666674 description "სამეცნიერო სტატია" @default.
- Q87666674 name "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 name "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 type Item @default.
- Q87666674 label "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 label "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 prefLabel "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 prefLabel "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 P1433 Q87666674-9D0AABCA-424D-4A63-A8D0-A7EAF31DCC7E @default.
- Q87666674 P1476 Q87666674-919FBD79-860B-48B9-8B6F-F0A620592918 @default.
- Q87666674 P2093 Q87666674-2342A449-9ECF-4627-BEDA-A528B7D48558 @default.
- Q87666674 P2093 Q87666674-33A77251-784E-4C35-B912-680EFEFC2302 @default.
- Q87666674 P2093 Q87666674-720105B8-D861-4FBD-9CE2-2FC68FEFD988 @default.
- Q87666674 P2093 Q87666674-75ED04CC-5E66-493D-82B4-CC5C7D2028DC @default.
- Q87666674 P2093 Q87666674-7DF36CE0-A321-4C2A-8F99-68121AC7EE48 @default.
- Q87666674 P2093 Q87666674-AABF72E8-76F6-449E-8BEE-1369BB233196 @default.
- Q87666674 P304 Q87666674-A53C77B3-AFCC-4E51-8F2F-19002B4B52FE @default.
- Q87666674 P31 Q87666674-E4D31290-9FE4-4DE6-AB5D-EF4437C701CC @default.
- Q87666674 P356 Q87666674-EFFE8EA2-5E63-4CE9-903A-708DAA7AE799 @default.
- Q87666674 P433 Q87666674-E7D6E4C0-2049-49D3-8754-8DE2643650B0 @default.
- Q87666674 P478 Q87666674-59EF5E4A-4E21-4D76-A9AA-85732563D3BE @default.
- Q87666674 P50 Q87666674-61364457-5E18-4593-8C15-D832B5D4F6AD @default.
- Q87666674 P577 Q87666674-BD1747EF-FF6D-4D60-BF02-E190410B1B3E @default.
- Q87666674 P698 Q87666674-EFE90239-80D3-4DE5-9925-89935DBA0782 @default.
- Q87666674 P921 Q87666674-0C4205F1-B11E-452F-AD67-CE41D6356543 @default.
- Q87666674 P921 Q87666674-5FAA2239-CAC7-4753-BB7D-2BEBC557A535 @default.
- Q87666674 P921 Q87666674-643A1236-08DB-4780-89F4-FC93740A367B @default.
- Q87666674 P921 Q87666674-D80A4786-A319-43D4-8F47-D8EC93F7E5F8 @default.
- Q87666674 P932 Q87666674-A560C795-C1D6-4F0E-9869-221FEEC8F8A6 @default.
- Q87666674 P356 MDX812 @default.
- Q87666674 P698 29390097 @default.
- Q87666674 P1433 Q326122 @default.
- Q87666674 P1476 "Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness" @default.
- Q87666674 P2093 "E D Hsi" @default.
- Q87666674 P2093 "J C Byrd" @default.
- Q87666674 P2093 "J L Johnson" @default.
- Q87666674 P2093 "J P Leonard" @default.
- Q87666674 P2093 "M S Czuczman" @default.
- Q87666674 P2093 "S Jung" @default.
- Q87666674 P304 "2271" @default.
- Q87666674 P31 Q13442814 @default.
- Q87666674 P356 "10.1093/ANNONC/MDX812" @default.
- Q87666674 P433 "11" @default.